Hims & Hers Health, Inc.·4

Jun 15, 5:12 PM ET

Pendarvis Christiane 4

Research Summary

AI-generated summary

Updated

Hims & Hers (HIMS) Director Christiane Pendarvis Exercises RSUs

What Happened

  • Christiane Pendarvis, a director of Hims & Hers Health, Inc. (HIMS), had 3,656 restricted stock units (RSUs) convert into 3,656 shares on June 11, 2026. The filing shows a simultaneous disposition of 3,656 shares at $0.00. No cash proceeds are reported for the disposition.
  • This was not a market purchase or sale for cash; it reflects conversion/settlement of RSUs rather than an independent buy/sell that signals a trading view.

Key Details

  • Transaction date: 2026-06-11; Form 4 filed 2026-06-15 (timely within the 2 business-day filing requirement).
  • Acquired: 3,656 shares via exercise/conversion of derivative (RSU conversion). Disposed: 3,656 shares at $0.00.
  • Reported dollar value of disposed shares: $0.00.
  • Shares owned after the transaction: not disclosed in the filing.
  • Footnote: RSUs represent a contingent right to one share each and were set to vest on the earlier of the 2026 annual meeting or June 15, 2026.

Context

  • For RSU conversions, it's common for a matching number of shares to be withheld or transferred to cover tax withholding at vesting; the zero-dollar disposal shown here is consistent with that practice.
  • This filing records the vesting/conversion event rather than a market trade indicating insider sentiment.